Get the Stockscreener App
5.0482
0.00%
0.0082
Precision Biosciences Inc stock is traded at $5.0482, with a volume of 23,963.
It is up +0.00% in the last 24 hours and down -2.14% over the past month.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
See More
Previous Close:
$5.04
Open:
$5.03
24h Volume:
23,963
Relative Volume:
0.10
Market Cap:
$59.17M
Revenue:
$52.29M
Net Income/Loss:
$-73.52M
P/E Ratio:
-7.6488
EPS:
-0.66
Net Cash Flow:
$-100.45M
1W Performance:
+8.15%
1M Performance:
-2.14%
6M Performance:
-8.20%
1Y Performance:
-48.09%
1-Day Range:
$4.943
$5.0982
1-Week Range:
$4.55
$5.18
52-Week Range:
$3.61
$11.09
Precision Biosciences Inc Stock (DTIL) Company Profile
Name
Precision Biosciences Inc
Sector
Industry
Phone
919-314-5512
Address
302 EAST PETTIGREW STREET, DURHAM, NC
Compare DTIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
5.02 | 60.47M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.30 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.25 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.03 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
704.24 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
299.25 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-30-24 | Initiated | Guggenheim | Buy |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Jun-09-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-27-20 | Resumed | BTIG Research | Buy |
| Apr-03-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-05-20 | Initiated | Stifel | Buy |
| Feb-25-20 | Initiated | William Blair | Outperform |
| Aug-09-19 | Initiated | BTIG Research | Buy |
| Jul-16-19 | Initiated | H.C. Wainwright | Buy |
| Apr-22-19 | Initiated | Barclays | Overweight |
| Apr-22-19 | Initiated | Goldman | Buy |
| Apr-22-19 | Initiated | JP Morgan | Overweight |
| Apr-22-19 | Initiated | Jefferies | Buy |
View All
Precision Biosciences Inc Stock (DTIL) Latest News
Precision BioSciences Inc.’s volatility index tracking explainedWall Street Watch & Safe Capital Growth Tips - Newser
AI Trend Models Suggest Bounce for Precision BioSciences Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Will Precision BioSciences Inc. continue its uptrendJuly 2025 Highlights & Free Verified High Yield Trade Plans - Newser
Will breakout in Precision BioSciences Inc. lead to full recoveryJuly 2025 Action & Weekly Return Optimization Alerts - Newser
How high can Precision BioSciences Inc. stock go2025 Volatility Report & Safe Capital Preservation Plans - Newser
Will Precision BioSciences Inc. stock go up soonJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser
What technical models suggest about Precision BioSciences Inc.’s comebackWeekly Profit Summary & Daily Risk Controlled Trade Plans - Newser
Visual analytics tools that track Precision BioSciences Inc. performanceJuly 2025 Sector Moves & Verified Short-Term Plans - Newser
Will Precision BioSciences Inc. price bounce be sustainableSwing Trade & Long-Term Safe Investment Ideas - Newser
Applying big data sentiment scoring on Precision BioSciences Inc.Global Markets & Weekly Momentum Stock Picks - Newser
Tools to assess Precision BioSciences Inc.’s risk profileJuly 2025 Patterns & Community Consensus Trade Alerts - Newser
Published on: 2025-08-25 23:47:24 - mustnews.co.kr
Aug Summary: Is Precision BioSciences Inc. a stock for growth or value investorsQuarterly Earnings Summary & Community Verified Swing Trade Signals - theviewers.co.kr
Using R and stats models for Precision BioSciences Inc. forecastingWeekly Trade Summary & Low Drawdown Investment Strategies - Newser
What recovery options are there for Precision BioSciences Inc.2025 Technical Overview & Advanced Technical Analysis Signals - Newser
What is Precision BioSciences Inc. s P E ratio telling us2025 Market Trends & Low Risk Entry Point Guides - theviewers.co.kr
Recovery Signals Appearing in Precision BioSciences Inc. ChartsWatch List & Precise Swing Trade Entry Alerts - beatles.ru
Layoff Tracker: Opthea Slashes 80% of Workforce, 50% of Board - BioSpace
Published on: 2025-08-17 21:42:46 - Newser
How Precision BioSciences Inc. stock performs during market volatilityJuly 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Can momentum traders help lift Precision BioSciences Inc.Market Risk Report & Free Low Drawdown Momentum Trade Ideas - Newser
Can Precision BioSciences Inc. recover in the next quarterMarket Sentiment Review & Safe Swing Trade Setup Alerts - Newser
Why Precision BioSciences Inc. stock attracts strong analyst attentionRisk Management & Fast Moving Market Watchlists - Newser
Precision Biosciences shares fall 1.89% premarket after Tyra Biosciences reports financial results and corporate progress. - AInvest
Precision Biosciences shares rise 1.60% premarket after Quanterix Corporation's executive leadership team presentation at Canaccord Genuity 45th Annual Growth Conference. - AInvest
Precision BioSciences Reports Significant Quarterly Loss - TipRanks
Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates - MSN
Applying Elliott Wave Theory to Precision BioSciences Inc.Algorithmic Forecast for Swing Trading Picks - Newser
Is Precision BioSciences Inc. stock entering bullish territorySafe Investment Ideas with Growth Upside - Newser
Precision BioSciences: Q2 Earnings Snapshot - Connecticut Post
DTIL Revenue Drops 99% - AOL.com
Precision BioSciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
Precision BioSciences Reports Second Quarter 2025 Financial Resu - GuruFocus
TR | OpenAI4o Maintains Precision BioSciences(DTIL.US) With Hold Rating, Maintains Target Price $5 - 富途牛牛
Precision Biosciences Inc Stock (DTIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
9.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):